Fighting MRSA with new membrane-busting compounds

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases. ...

Developing oral medicines that work more efficiently

Researchers at the University of Minnesota and The Dow Chemical Company have joined forces to tackle one of the biggest challenges in health care—how to get life-saving medicines to work faster and better with fewer side ...

page 2 from 2